$90.35−0.01 (−0.01%)
Market open · 15-min delayed · as of 9:44 AM ET
10x Genomics Inc · Statistics
Cheap or expensive, strong or fragile. Every ratio ranked against its sector peers — the number we score — with its own ten-year record shown beside it for context.
VALUE
Rich vs sector
premium price vs peers
QUALITY
Weak
below-peer returns
HEALTH
Sturdy
leverage data unavailable; scored on the rest
GROWTH
Fair
steady, not spectacular
In one line
A weak business at a rich price for its sector: value 19, quality 34, health 86, growth 66, each a percentile within Technology.
track = where peers land, worse → better (direction-adjusted: right always means better)▏sector median● you are here▲ where today's value sits in the company's own 10-year record (context, not scored)hover any metric for its formula
Valuation
19th pctilepremium price vs peersEBIT (operating income) for the latest fiscal year ÷ enterprise value on the current market cap (Greenblatt). The vendor's own earnings yield is net income to common ÷ market cap, a different figure.—excluded: no value on file for this company
Financial health
86th pctileleverage data unavailable; scored on the rest(Cash, short-term investments and receivables) ÷ current liabilities, as the data vendor builds it. Its receivables include non-trade receivables, which Tenet's balance sheet shows inside other current assets.3.9587th pctileFiscal 2025 (Dec 31, 2025)
(Total debt − cash) ÷ EBITDA—excluded: negative EBITDA denominator
Profitability & returns
34th pctilebelow-peer returnsAltman's bankruptcy-distance score for the latest fiscal year, with its market-value term at the fiscal year end; higher is safer, as the data vendor publishes it (vendor definition, not reproduced).4.157th pctileFiscal 2025 (Dec 31, 2025)
Growth
66th pctilesteady, not spectacularThe yearly rate that compounds the oldest fiscal year's revenue into the latest one, over the true number of fiscal years between them (up to five).+16.6%64th pctileFiscal 2020 to fiscal 2025, 5 years: revenue $298.8M to $642.8M
★ Corrected metrics: why we compute these ourselves
the receipts behind the numbers aboveGreenblatt earnings yield—EBIT ÷ EV The vendor's "earningsYield" is NI ÷ market cap, which is not Greenblatt's formula.
ROIC−5%NOPAT ÷ invested capital The vendor's simple ROIC, not its tiny-base roic tag; withheld when a negative EBIT flips its sign.
Interest coverage— Guarded, not faked: we have no interest-expense figure on file for this company, so it's excluded from the ranking instead of rendered as garbage.
Every raw line behind these ratios→
All three statements: 5 years free, 10 on Premium, 20 on Ultimate
Quarterly, in fiscal years: 1 free, 5 on Premium, Unlimited on Ultimate
These percentiles feed the value, income, timing and long-hold tenets→
See which criteria pass, with the live number and the rule behind each
Percentiles computed nightly against 489 Technology peers from our ingested fundamentals DB · raw statements for corrected metrics. Direction-adjusted: for "lower is better" ratios (P/E, D/E…) the percentile is flipped so right always means better. The percentile is the stock's rank among sector peers, the number that is scored. The triangle marks where the current value sits in the company's own ten-year annual record, shown for context and never blended into the score. Computed 2026-10-01 · Not investment advice.